Wegman Mark N 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed May 23, 2019
Insider Transaction Report
Form 4
Wegman Mark N
Director
Transactions
- Sale
Common Stock, $0.001 par value
2019-05-22$63.70/sh−1,200$76,440→ 73,072 total
Footnotes (1)
- [F1]The selling price of $63.70 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $63.41 to $63.82. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.